StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q3 FY26 Results

SAMRATPHQ3 FY26 Results
Filing
MetricValue ( Cr)Q2 FY26Q3 FY25
Revenue63.4319.6%0.4%
Total Income63.8319.1%0.3%
Expenditure64.3919.2%7.8%
PBT-0.5724.2%114.5%
Net Profit-0.4621.8%116.5%
OPM-1.04%0.58pp6.77pp
NPM-0.72%0.02pp5.09pp
EPS1.4921.6%83.5%
View full financials

Informational and educational content only. Not investment advice.